Similar findings were obtained with the genetic and pharmacological knockdown of the Ca2+-activated K+ channel KCa3.1 in an IBD model (Di et al., 2010; Ohya et al., 2014; Ohya and Imaizumi, 2014). Here, KCNN4 is linked to inflammatory bowel disease.